Asian J andrology
Ji S, An F, Zhang T, Lou M, Guo J, Liu K, Zhu Y, Wu J, Wu R
Richness of human gut microbiome correlates with metabolic markers
Yes, and many clinicians intentionally prescribe both peptides concurrently for patients with combined goals
Moreover, intrauterine devices (IUD) releasing levonorgestrel are a very suitable option for cases with adenomyosis and increased risk for thrombotic conditions for whom systemic therapy could not be advisable [61, 62] (e.g., women above 40 years old, increased BMI, increased risk for estrogen-dependent diseases such as breast cancer or endometrial hyperplasia)